This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Sharps Compliance Crecimiento futuro
Future controles de criterios 3/6
Información clave
55.0%
Tasa de crecimiento de los beneficios
52.1%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Healthcare | 17.2% |
| Tasa de crecimiento de los ingresos | 5.1% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | n/a |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Aurora Capital Partners affiliate to acquire Sharps Compliance for $8.75 per share
Jul 12We Like These Underlying Return On Capital Trends At Sharps Compliance (NASDAQ:SMED)
Jul 02
Is Sharps Compliance (NASDAQ:SMED) Using Too Much Debt?
Jun 13Sharps Compliance Corp.'s (NASDAQ:SMED) Shareholders Might Be Looking For Exit
May 25Here's Why I Think Sharps Compliance (NASDAQ:SMED) Might Deserve Your Attention Today
May 03Sharps Compliance: Update Prior To Important Earnings
Apr 26Sharps Compliance: An Operator In The Medical Waste Industry
Jan 04Is Sharps Compliance (NASDAQ:SMED) Using Too Much Debt?
Dec 06Time To Worry? Analysts Just Downgraded Their Sharps Compliance Corp. (NASDAQ:SMED) Outlook
Aug 20These 4 Measures Indicate That Sharps Compliance (NASDAQ:SMED) Is Using Debt Reasonably Well
Jun 18Sharps Compliance: Undervalued, Even If Growth Returns To Historical Levels
Jun 04With EPS Growth And More, Sharps Compliance (NASDAQ:SMED) Is Interesting
May 20Are Investors Undervaluing Sharps Compliance Corp. (NASDAQ:SMED) By 39%?
May 07Sharps Compliance EPS beats by $0.27, beats on revenue
Apr 28What Type Of Shareholders Own The Most Number of Sharps Compliance Corp. (NASDAQ:SMED) Shares?
Mar 15Has Sharps Compliance (NASDAQ:SMED) Got What It Takes To Become A Multi-Bagger?
Mar 01Upgrade: Analysts Just Made A Substantial Increase To Their Sharps Compliance Corp. (NASDAQ:SMED) Forecasts
Feb 02Earnings Beat: Sharps Compliance Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 01Is Sharps Compliance (NASDAQ:SMED) Weighed On By Its Debt Load?
Jan 26Sharps Compliance reports robust order activity
Jan 11Is There An Opportunity With Sharps Compliance Corp.'s (NASDAQ:SMED) 33% Undervaluation?
Jan 05
Don't Ignore The Fact That This Insider Just Sold Some Shares In Sharps Compliance Corp. (NASDAQ:SMED)
Dec 18Shareholders Are Thrilled That The Sharps Compliance (NASDAQ:SMED) Share Price Increased 117%
Dec 07Is Sharps Compliance Corp. (NASDAQ:SMED) Popular Amongst Insiders?
Nov 18Does Sharps Compliance (NASDAQ:SMED) Have A Healthy Balance Sheet?
Jul 24Does The Market Have A Low Tolerance For Sharps Compliance Corp.'s (NASDAQ:SMED) Mixed Fundamentals?
Jul 06Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 6/30/2024 | 77 | 5 | 7 | 8 | 1 |
| 6/30/2023 | 65 | 1 | 2 | 4 | 2 |
| 6/30/2022 | 65 | -1 | -6 | -4 | 2 |
| 3/31/2022 | 69 | 4 | 3 | 5 | N/A |
| 12/31/2021 | 79 | 11 | 12 | 14 | N/A |
| 9/30/2021 | 77 | 12 | 15 | 17 | N/A |
| 6/30/2021 | 76 | 13 | 19 | 22 | N/A |
| 3/31/2021 | 70 | 10 | 2 | 7 | N/A |
| 12/31/2020 | 53 | 2 | -3 | 2 | N/A |
| 9/30/2020 | 51 | 1 | -3 | 2 | N/A |
| 6/30/2020 | 51 | 2 | -3 | 1 | N/A |
| 3/31/2020 | 51 | 1 | -2 | 1 | N/A |
| 12/31/2019 | 50 | 1 | -1 | 1 | N/A |
| 9/30/2019 | 48 | 1 | 0 | 1 | N/A |
| 6/30/2019 | 44 | 0 | 0 | 1 | N/A |
| 3/31/2019 | 42 | 0 | 0 | 2 | N/A |
| 12/31/2018 | 42 | 0 | 1 | 2 | N/A |
| 9/30/2018 | 41 | -1 | 1 | 2 | N/A |
| 6/30/2018 | 40 | -1 | 1 | 2 | N/A |
| 3/31/2018 | 41 | 0 | 0 | 1 | N/A |
| 12/31/2017 | 40 | 0 | -1 | 1 | N/A |
| 9/30/2017 | 38 | 0 | -1 | 1 | N/A |
| 6/30/2017 | 38 | -1 | -3 | -1 | N/A |
| 3/31/2017 | 37 | -2 | -3 | 0 | N/A |
| 12/31/2016 | 35 | -2 | -3 | 1 | N/A |
| 9/30/2016 | 35 | -1 | -3 | -1 | N/A |
| 6/30/2016 | 33 | 0 | -1 | 1 | N/A |
| 3/31/2016 | 34 | 1 | -1 | 1 | N/A |
| 12/31/2015 | 33 | 1 | N/A | 1 | N/A |
| 9/30/2015 | 32 | 1 | N/A | 1 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: SMED's forecast earnings growth (55% per year) is above the savings rate (1.9%).
Beneficios vs. Mercado: SMED's earnings (55% per year) are forecast to grow faster than the US market (14.2% per year).
Beneficios de alto crecimiento: SMED's earnings are expected to grow significantly over the next 3 years.
Ingresos vs. Mercado: SMED's revenue (5.1% per year) is forecast to grow slower than the US market (7.7% per year).
Ingresos de alto crecimiento: SMED's revenue (5.1% per year) is forecast to grow slower than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if SMED's Return on Equity is forecast to be high in 3 years time